X-25013543-GCGGCCGCGGCTGCCGCGGCGGCCC-GCGGCCGCGGCTGCCGCGGCGGCCCCGGCCGCGGCTGCCGCGGCGGCCC

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 7P and 4B. PS3PM4PP5BS2

The NM_139058.3(ARX):​c.428_451dupGGGCCGCCGCGGCAGCCGCGGCCG​(p.Gly143_Ala150dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000189 in 794,926 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000829094: Studies have shown that this variant alters ARX gene expression (PMID:17331656).". Synonymous variant affecting the same amino acid position (i.e. A151A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000077 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.000010 ( 0 hom. 2 hem. )

Consequence

ARX
NM_139058.3 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:5U:1

Conservation

PhyloP100: 0.378

Publications

20 publications found
Variant links:
Genes affected
ARX (HGNC:18060): (aristaless related homeobox) This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]
ARX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • intellectual disability, X-linked, with or without seizures, ARX-related
    Inheritance: XL Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, G2P
  • Partington syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked lissencephaly with abnormal genitalia
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • corpus callosum agenesis-abnormal genitalia syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile epileptic-dyskinetic encephalopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked spasticity-intellectual disability-epilepsy syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000829094: Studies have shown that this variant alters ARX gene expression (PMID: 17331656).
PM4
Nonframeshift variant in NON repetitive region in NM_139058.3.
PP5
Variant X-25013543-G-GCGGCCGCGGCTGCCGCGGCGGCCC is Pathogenic according to our data. Variant chrX-25013543-G-GCGGCCGCGGCTGCCGCGGCGGCCC is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 11187.
BS2
High AC in GnomAd4 at 8 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139058.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARX
NM_139058.3
MANE Select
c.428_451dupGGGCCGCCGCGGCAGCCGCGGCCGp.Gly143_Ala150dup
conservative_inframe_insertion
Exon 2 of 5NP_620689.1Q96QS3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARX
ENST00000379044.5
TSL:1 MANE Select
c.428_451dupGGGCCGCCGCGGCAGCCGCGGCCGp.Gly143_Ala150dup
conservative_inframe_insertion
Exon 2 of 5ENSP00000368332.4Q96QS3

Frequencies

GnomAD3 genomes
AF:
0.0000767
AC:
8
AN:
104289
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.000237
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000200
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000101
AC:
7
AN:
690637
Hom.:
0
Cov.:
30
AF XY:
0.00000954
AC XY:
2
AN XY:
209747
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000226
AC:
3
AN:
13291
American (AMR)
AF:
0.00
AC:
0
AN:
2076
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
5137
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5297
South Asian (SAS)
AF:
0.0000664
AC:
1
AN:
15058
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4259
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1292
European-Non Finnish (NFE)
AF:
0.00000484
AC:
3
AN:
620414
Other (OTH)
AF:
0.00
AC:
0
AN:
23813
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000767
AC:
8
AN:
104289
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
29767
show subpopulations
African (AFR)
AF:
0.000237
AC:
7
AN:
29549
American (AMR)
AF:
0.00
AC:
0
AN:
10216
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2546
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3238
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2468
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3911
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000200
AC:
1
AN:
50102
Other (OTH)
AF:
0.00
AC:
0
AN:
1414
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
1
-
not provided (2)
1
-
-
Developmental and epileptic encephalopathy, 1 (1)
1
-
-
Intellectual disability, X-linked, with or without seizures, ARX-related (1)
1
-
-
Intellectual disability, X-linked, with or without seizures, ARX-related;C3463992:Developmental and epileptic encephalopathy, 1 (1)
1
-
-
Partington syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.38

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387906493; hg19: chrX-25031660; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.